Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

KaiBiLi Extended ViralTrans

K-Number: K231027 · 2023-12-21

Decision Date2023-12-21
Product CodeJSM
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

KaiBiLi Extended ViralTrans is a medical device manufactured by Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.. It received FDA 510(k) clearance on 2023-12-21 under approval number K231027. The device is classified under product code JSM. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the KaiBiLi Extended ViralTrans?

KaiBiLi Extended ViralTrans is a medical device that received FDA 510(k) clearance on 2023-12-21. It is manufactured by Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.. The 510(k) number is K231027.

When was KaiBiLi Extended ViralTrans approved by the FDA?

KaiBiLi Extended ViralTrans received FDA 510(k) clearance on 2023-12-21, under approval number K231027.

What company makes KaiBiLi Extended ViralTrans?

KaiBiLi Extended ViralTrans is manufactured by Hangzhou Genesis Biodetection & Biocontrol Co., Ltd..

What is the FDA product code for KaiBiLi Extended ViralTrans?

The FDA product code for KaiBiLi Extended ViralTrans is JSM.

Related Devices (Code: JSM)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.